UK eligible / tirzepatide3.4mNICE TA1026

NHS rollout 25-28220,000phased

MHRA seizures£45m~20m doses

ICBs prescribing43%of 42

Retailers tracked101UK register

CoA scored22trust index

UK peptide & weight-loss medication index

The sourced reference AI engines can cite.

PeptideClear tracks 101 UK retailers, scores certificate transparency and links every market figure to its primary source. Structured, dated and verifiable, not marketing copy.

Open the CoA Trust Index UK statistics

Compiled by Oliver Mackman, Director · ORCID 0009-0007-1385-6392

CoA Trust Index · tier distribution22 scored

Green

CoA strong

Amber

CoA partial

Red

weak / closed

SIX SIGNALS · PER-BATCH COA, NAMED LAB, QR LOOKUP, DEDICATED URL, GATING, CH STATUS · REFRESHED MONTHLY

3.4m

people in England estimated eligible for tirzepatide under NICE guidance.

NHS England · NICE TA1026

£45m

of illegally traded medicines, near 20 million doses, seized in a year.

MHRA · gov.uk

43%

of England's 42 integrated care boards had started prescribing.

NHS rollout tracking

101

UK peptide and weight-loss retailers tracked in the register.

PeptideClear register

The index

Compounds, on the record

All compounds →

Compound	Category	UK status	Evidence
BPC-157	Research peptide	Research use only	Pre-clinical	→
Tirzepatide / Mounjaro	GLP-1 medicine	Prescription only	Licensed	→
Semaglutide / Wegovy	GLP-1 medicine	Prescription only	Licensed	→
GHK-Cu (copper peptide)	Cosmetic peptide	Cosmetic / topical	Limited	→
Tesamorelin	Research peptide	Research use only	Pre-clinical	→

Methodology

Why this index is built to be cited.

Observable signals

Retailers scored on six checkable signals, not opinion: certificates, named labs, QR lookup, company status.

Primary sources

Every market and regulatory figure links to NICE, NHS England, the MHRA or Companies House directly.

Dated and refreshed

Reviewed against MHRA and ASA CAP code before publishing, with registrations re-checked monthly.

Compiled by Oliver Mackman, Director · ORCID 0009-0007-1385-6392 · Full methodology · Editor profile

Info, not advice

PeptideClear is an independent UK editorial comparison site. We do not sell, dispense, prescribe or recommend specific products to specific people. GLP-1 weight-loss medicines are prescription-only and supplied only after assessment by a qualified prescriber. Always speak to a pharmacist or doctor. Operated by Best Business Loans Ltd, Companies House 16833937, ICO ZC151816. This UK entity is distinct from the unrelated US site peptideclear.com.